TherapeuticsMD Inc logo

TXMD

TherapeuticsMD Inc

$10.15

Earnings Summary

Revenue
$19.33Mn
Net Profits
$-49.02Mn
Net Profit Margins
-253.56%

Highlights

Revenue:

TherapeuticsMD Inc’s revenue fell -2.68% since last year same period to $19.33Mn in the Q1 2022. On a quarterly growth basis, TherapeuticsMD Inc has generated 3.51% jump in its revenue since last 3-months.

Net Profits:

TherapeuticsMD Inc’s net profit fell -24.47% since last year same period to $-49.02Mn in the Q1 2022. On a quarterly growth basis, TherapeuticsMD Inc has generated -14.11% fall in its net profits since last 3-months.

Net Profit Margins:

TherapeuticsMD Inc’s net profit margin fell -27.9% since last year same period to -253.56% in the Q1 2022. On a quarterly growth basis, TherapeuticsMD Inc has generated -10.24% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the TherapeuticsMD Inc post its latest quarter earnings

EPS Estimate Current Quarter
-2.92
EPS Estimate Current Year
-2.92

Highlights

EPS Estimate Current Quarter:

TherapeuticsMD Inc’s earning per share (EPS) estimates for the current quarter stand at -2.92 - a 27% jump from last quarter’s estimates.

EPS Estimate Current Year:

TherapeuticsMD Inc’s earning per share (EPS) estimates for the current year stand at -2.92.

Key Ratios

Key ratios of the TherapeuticsMD Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-5.69
Return on Assets (ROA)
-0.45
Return on Equity (ROE)
0
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

TherapeuticsMD Inc’s earning per share (EPS) fell -3.45% since last year same period to -5.69 in the Q1 2022. This indicates that the TherapeuticsMD Inc has generated -3.45% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. TherapeuticsMD Inc’s return on assets (ROA) stands at -0.45.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. TherapeuticsMD Inc’s return on equity (ROE) stands at 0.

Dividend Per Share (DPS):

TherapeuticsMD Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-16
-4
-5.69
-42.25%

Company Information

TherapeuticsMD Inc. is an inventive pharmaceutical company that focuses exclusively on healthcare products for women and informs on women’s health problems. The company is dedicated to producing advanced therapeutic products related to family planning, reproductive health, and menopause management with the view to addressing the unique challenges that women face in the different phases of their lives. Founded in 2008 by Brian Bernick and Robert Finizio, the company is headquartered in Boca Raton, Florida. TherapeuticsMD delivers bio-identical hormones in various forms and administration methods using its homegrown SYMBODA technology. It makes fetal vitamins and other nutritional supplements under its vitaMedMD brand and exclusively prescribed prenatal vitamins through BocaGreenMD. These products are produced by a third-party manufacturer- Lang Pharma Nutrition. The company's solutions include long-lasting contraceptives, pharmaceutical products for hormone therapy, and patient-controlled contraceptives. Aside from developing prescription-only hormone therapy products for women, TherapeuticsMD is designing products to address menopausal vasomotor symptoms and dyspareunia. Currently, the firm markets and sells its products through a direct national sales force of about 50 full-time professionals that target health care providers in the OB/GYN sector. Medical professionals may also be able to provide patients with an alternative that meets their individual nutritional and financial needs about co-pays and costs of care and saves them money compared with competing products.. Currently TherapeuticsMD Inc has a market cap of $0.09 Billion. It has a P.E ratio of -0.46. The shares of TherapeuticsMD Inc are trading at $9.91. .

Organisation
TherapeuticsMD Inc
Headquarters
Boca Raton, Florida, United States
Employees
400
Industry
Health Technology
CEO
Robert Finizio